Markel Group’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,112
Closed -$1.62M 125
2021
Q3
$1.62M Hold
4,112
0.02% 109
2021
Q2
$1.89M Hold
4,112
0.02% 108
2021
Q1
$1.54M Hold
4,112
0.02% 105
2020
Q4
$1.48M Hold
4,112
0.02% 105
2020
Q3
$1.24M Hold
4,112
0.02% 105
2020
Q2
$1.48M Hold
4,112
0.03% 104
2020
Q1
$1.09M Buy
4,112
+3,084
+300% +$862K 0.02% 120
2019
Q4
$332K Hold
1,028
﹤0.01% 132
2019
Q3
$304K Hold
1,028
﹤0.01% 132
2019
Q2
$368K Hold
1,028
0.01% 131
2019
Q1
$311K Hold
1,028
0.01% 132
2018
Q4
$300K Hold
1,028
0.01% 129
2018
Q3
$367K Hold
1,028
0.01% 129
2018
Q2
$279K Hold
1,028
0.01% 130
2018
Q1
$236K Hold
1,028
﹤0.01% 137
2017
Q4
$218K Buy
+1,028
New +$212K ﹤0.01% 138

Other funds holding ILMN

Markel Group's ILMN Position: Q4 2021 in Review

Markel Group sold out of Illumina (ILMN) in Q4 2021, closing a stake of 4,112 shares — an estimated $1.62M sold.

Markel Group first reported a position in ILMN in Q4 2017 and held it in 16 quarters. The position peaked at $1.89M in Q2 2021. 1,066 funds tracked by Wall St. Rank hold ILMN as of Q4 2021.

  • Markel Group reported no remaining Illumina position as of Q4 2021 after selling out during the quarter.
  • Markel Group sold 4,112 Illumina shares in Q4 2021, an estimated $1.62M.
  • Markel Group first reported a position in Illumina in Q4 2017 and held it in 16 quarters.
  • Markel Group's Illumina position peaked at $1.89M in Q2 2021.
  • 1,066 funds tracked by Wall St. Rank held Illumina as of Q4 2021.

Based on Markel Group's 13F filing for Q4 2021, filed 4 Feb 2022.